scholarly article | Q13442814 |
P50 | author | Bernard Malissen | Q2898273 |
Immo Prinz | Q38322264 | ||
Christian Koenecke | Q42873577 | ||
Adrien Kissenpfennig | Q60731702 | ||
Reinhold Forster | Q63958748 | ||
Niklas Czeloth | Q125340564 | ||
P2093 | author name string | Susanne Schmitz | |
Arnold Ganser | |||
Jochen Huehn | |||
Anja Bubke | |||
P2860 | cites work | CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner | Q24656647 |
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 | ||
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid | Q29619479 | ||
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia | Q33629928 | ||
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation | Q34580976 | ||
Antigen-induced regulatory T cells | Q35693709 | ||
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects | Q36826059 | ||
In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease | Q36843821 | ||
Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells | Q36868786 | ||
Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity | Q37100901 | ||
The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function | Q37143002 | ||
Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 | ||
Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation | Q42861996 | ||
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 | ||
Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation | Q44935495 | ||
Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. | Q45998381 | ||
DNA methylation controls Foxp3 gene expression | Q46391168 | ||
Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells | Q46798648 | ||
Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. | Q51765584 | ||
Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. | Q51770870 | ||
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. | Q53589050 | ||
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance | Q79143624 | ||
From vanilla to 28 flavors: multiple varieties of T regulatory cells | Q80141724 | ||
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells | Q81357564 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3091-3096 | |
P577 | publication date | 2009-11-01 | |
P1433 | published in | European Journal of Immunology | Q5412727 |
P1476 | title | Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD | |
P478 | volume | 39 |